FirstAlerts

FDA Reports Ongoing Class II Recall of Convenience Kits from Medline and AVID Medical

The U.S. Food and Drug Administration has reported an ongoing Class II recall of convenience kits distributed by Medline and AVID Medical due to sterility concerns.

5 reports on this incident · first at Sep 2, 2026, 7:11 p.m. ET

By AI ReporterFirst reported Sep 2, 2026, 12:00 a.m. ETUpdated Sep 7, 2026, 2:21 p.m. ET
The U.S. Food and Drug Administration (FDA) has reported an of convenience kits distributed by and , according to fda.gov. The recall was reported on September 2, 2026. The kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components intended for use during various surgical procedures. Affected kits carry one of the following identifying codes: 1703122, 1707656, 1708053, 1641713, 1641714, 1659697, 1668209, 1652485, 1656642, 1667835, 1676219, 1682251, 1691940, 1668365, 1668366, 1688166, 1692637, or 1696930. The recall stems from concerns about sterility. According to fda.gov, the issue involves a potential breach of sterility in the packaging due to wrinkles in the paper lidding which may extend to the seal area, or the affected product may exhibit an open or incomplete seal on the packaging of the applicator. Separately, fda.gov reports that . As of August 10, has reported no serious injuries and no deaths associated with this issue, while as of August 3, has reported no serious injuries or deaths, according to fda.gov. The FDA advises users not to use sodium chloride ampules included in affected kits, to check stock for convenience kits containing sodium chloride ampules, and to quarantine kits until new labels can be printed and affixed to all kits. Separately, the agency instructs users to remove affected BD ChloraPrep applicators and apply over-labels to all affected kits on hand stating that the affected components must be removed and discarded prior to use.

Earlier reports

  1. Sep 2, 2026, 7:22 p.m. ET

    FDA Expands Medline Convenience Kit Recall Over Sterility Concern

    The FDA has expanded a recall of Medline convenience kits containing BD ChloraPrep applicators, according to a notice published September 2, 2026. The kits, which include surgical instruments, dressings, and pharmaceutical components for various procedures, may have compromised sterile barriers due to wrinkles in the paper lidding or an open or incomplete seal on the applicator packaging.

    Medline is instructing users to remove affected BD ChloraPrep applicators and apply over-labels to all affected kits on hand stating that the components must be removed and discarded prior to use. As of August 3, Medline has reported no serious injuries or deaths associated with this issue, the FDA said.

    The recall is classified as Class II, indicating a situation where use of the product may cause temporary or medically reversible adverse health consequences. The FDA notice does not specify which lot codes are affected in this expansion.

  2. Sep 2, 2026, 7:21 p.m. ET

    FDA Reclassifies Medline Convenience Kit Recall as Class II

    The U.S. Food and Drug Administration has reclassified the Medline convenience kit correction as a Class II recall, according to an FDA notice dated September 2, 2026. The agency did not specify the previous classification in the notice.

    The correction applies to convenience kits containing BD ChloraPrep applicators. The kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components intended for use during surgical procedures. The reason for the correction is a potential breach of sterility in the packaging due to wrinkles in the paper lidding that may extend to the seal area, or an open or incomplete seal on the applicator packaging.

    If the sterile barrier is compromised, patients and users may be exposed to microbial contamination, with potential health consequences ranging from no injury to localized infection or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization. As of August 3, Medline has reported no serious injuries or deaths associated with this issue.

    The FDA instructs users to remove affected BD ChloraPrep applicators and apply over-labels to all affected kits on hand stating that the affected components must be removed and discarded prior to use.

  3. Sep 2, 2026, 7:15 p.m. ET

    FDA Reports No Serious Injuries or Deaths in Medline Convenience Kit Recall

    As of August 3, Medline has reported no serious injuries or deaths associated with a potential sterility issue in certain convenience kits, the U.S. Food and Drug Administration (FDA) announced on September 2, 2026.

    The FDA classified the action as a Class II recall. The affected convenience kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components intended for use during surgical procedures. The reason for the correction is a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area, or the affected product may exhibit an open or incomplete seal on the packaging of the applicator.

    If the sterile barrier is compromised, patients and users may be exposed to microbial contamination. Potential health consequences may include no injury, localized infection, or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization.

    Medline has instructed users to remove affected BD ChloraPrep applicators and apply over-labels to all affected kits on hand stating that the affected components must be removed and discarded prior to use.

  4. Sep 2, 2026, 7:11 p.m. ETFirst report

    Medline Recalls Convenience Kits Over Sterility Concern

    Medline has issued a correction for convenience kits containing BD ChloraPrep applicators, the U.S. Food and Drug Administration (FDA) announced on September 2, 2026. The recall is classified as Class II, according to the FDA.

    The reason for the correction is a potential breach of sterility in the packaging, due to wrinkles in the paper lidding that may extend to the seal area, or the affected product may exhibit an open or incomplete seal on the packaging of the applicator, the FDA reported. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination, with potential health consequences ranging from no injury to localized infection or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization.

    As of August 3, Medline has reported no serious injuries or deaths associated with this issue, according to the FDA. The convenience kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components intended for use during various surgical procedures.

    The FDA instructs users to remove affected BD ChloraPrep applicators and apply over-labels to all affected kits on hand stating that the affected components must be removed and discarded prior to use.

Was this report accurate and useful?

Sources

Revision history

  1. Version 27 Sept 2026, 18:21current

    Corrected status from closed to ongoing; updated remedy and hazard descriptions to reflect both FDA notices.

  2. Version 12 Sept 2026, 23:22current

    First published.

  3. Version 12 Sept 2026, 23:11current

    First published.

  4. Version 12 Sept 2026, 23:15current

    First published.

  5. Version 12 Sept 2026, 23:21current

    First published.

  6. Version 17 Sept 2026, 18:16

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.